Каталог
/
Медицина и здравоохранение
/
Фармакология
/
BioDrugs
BioDrugs
Издатель: Springer Nature ·
ISSN 1173-8804,1179-190X ·
121 статей
☆
Cell Engineering for Increasing Production of Recombinant Proteins in Mammalian Cells
Xi Zhang, Yuan Shen, Zihan Guo, Yanfang Wang, Xiaoyin Wang, Tianyun Wang
BioDrugs
· Фармакология
· 2025-11-20
☆
Clinical Qualification of Subcutaneous Injection Devices for Monoclonal Antibodies
Beate Bittner, Javier Munoz, Sabine Frank, Michael Dolton, Renato Ravanello, Markus Dembowski, Aude Clement, Wolfgang F. Richter
BioDrugs
· Фармакология
· 2025-11-17
☆
Xeligekimab, an Interleukin-17A Antagonist for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 48-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study
Shangzhu Zhang, Dong Xu, Shengyun Liu, Shujie Li, Xiaoxia Wang, Fenghong Yuan, Wei Gou, Baijie Xu, Lingyun Sun, Jieruo Gu, Dongmei Zhou, Xiaomei Li, Ning Kong, Yi Zhao, Jie Hao, Tianwang Li, Xiaoyun Fan, Qiang Shu, Hua Wei, Tao Jiang, Jing Yang, Long Qian, Hongsheng Sun, Xiaoyan Cai, Zhenyu Jiang, Guohua Yuan, Li Qin, Min Yang, Jian Xu, Wenqiang Fan, Li Sun, Hua Zhang, Chunyan Zhang, Ning Zhang, Zhanyun Da, Jiankang Hu, Jingchun Jin, Ju Liu, Lie Dai, Lingli Dong, Wei Wang, Xiaofeng Zeng
BioDrugs
· Фармакология
· 2025-11-17
☆
Pharmacokinetic Similarity of Biosimiliar AVT05 Versus Reference Product Golimumab in Healthy Adults: A Double-Blind, Three-Arm, Parallel-Group Study
Chris Wynne, Ulrike Lorch, Edrich Krantz, Rohit Katial, Thomas Ashdown, Monica Luque, Abid Sattar, Masna Rai, Laxmikant Vashishta, Katarina Petrovic, Ruth Ruffieux, Steffen Leutz, Fausto Berti
BioDrugs
· Фармакология
· 2025-11-10
☆
Efficacy and Safety of Biosimilar AVT05 Versus Reference Product Golimumab in Combination with Methotrexate in Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results of a Randomized, Parallel-Group, Double-Blind Study
Monica Luque, Kristina Zhelyazkova, Laxmikant Vashishta, Masna Rai, Abid Sattar, Katarina Petrovic, Richard Bucknall, Steffen Leutz, Fausto Berti
BioDrugs
· Фармакология
· 2025-11-03
☆
Toward Regulatory Convergence and Streamlined Biosimilar Development: Recommendations from an International Qualitative Study
Elif Car, Liese Barbier, Ingrid Schwarzenberger, Isabelle Huys, Steven Simoens, Arnold G. Vulto
BioDrugs
· Фармакология
· 2025-10-21
☆
Biological Therapies in Chronic Obstructive Pulmonary Disease: New Directions in Personalised Respiratory Medicine
Benjamin Mappin-Kasirer, Ian D. Pavord
BioDrugs
· Фармакология
· 2025-10-04
☆
Bidirectional Interplay Between IBD Therapies and the Gut Microbiota: A Pharmacomicrobiomic Approach to Personalized Treatment
Slavica Lazarević, Maja Đanić, Nebojša Pavlović
BioDrugs
· Фармакология
· 2025-10-03
☆
Advances of Antimicrobial Peptides in the Treatment of Multidrug-Resistant Bacteria
Yuanzhi Ju, Luxi Weng, Tiantian Lin, Xiaohui Yang, Jiasheng Song, Jingxiang Wang, Huimin Su, Pengqin Chen, Wuping Shuai, Jia-Wei Shen, Yongzhong Du, Saiping Jiang
BioDrugs
· Фармакология
· 2025-10-02
☆
Risankizumab in Patients with Psoriasis with Current or Previous Malignancy: A Multicenter, Retrospective Real-World Study
Marco Sousa, Ana Luísa João, Martim Luz, Pedro Mendes-Bastos, Ângela Roda, Luiz Leite, Joana Valério, Ana Ferreirinha, Bárbara Leal, Maria João Paiva Lopes, Rita Pimenta, Paulo Ferreira, Tiago Torres
BioDrugs
· Фармакология
· 2025-10-01
☆
Oncolytic Virotherapy in Solid Tumors: A Current Review
Courtney Chen, Jennifer Cillis, Supriya Deshpande, Anthony K. Park, Hannah Valencia, Sang In Kim, Jianming Lu, Yoya Vashi, Annie Yang, Zhifang Zhang, Yanghee Woo, Yuman Fong, Shyambabu Chaurasiya
BioDrugs
· Фармакология
· 2025-09-24
☆
The Present and Future of Monoclonal Antibody Therapies for Multiple Sclerosis
Silvia Susin-Calle, Elvira Munteis, Pablo Villoslada, Jose E. Martinez-Rodriguez
BioDrugs
· Фармакология
· 2025-09-23
☆
Targeting CD20 for B-cell Depletion in Autoimmune Kidney Disease: Next Generation
Federico Yandian, Sanjeev Sethi, Fernando C. Fervenza, Fernando Caravaca-Fontán
BioDrugs
· Фармакология
· 2025-09-08
☆
Real-World Data Included in Post-authorisation Measures: A Case Study of Approved Advanced Therapy Medicinal Products in the European Union between 2013 and 2024
Diogo Almeida, Diana Mandslay, Peter G. M. Mol, Bruno Sepodes, Carla Torre
BioDrugs
· Фармакология
· 2025-08-26
☆
Introduction of Biopharmaceuticals in Europe: A Cross-Sectional Study of Early Diffusion Patterns and Data Availability
Ivar Veszelei, Brian Godman, Katri Aaltonen, Gisbert W. Selke, Kristina Garuolienė, Agnese Cangini, Amanj Kurdi, António Teixeira Rodrigues, Caridad Pontes, Carla Torre, Carlotta Lunghi, Edel Burton, Elita Poplavska, Freyja Jónsdóttir, Guenka Petrova, Irene Langner, Irina Iaru, Irina Odnoletkova, Juraj Slabý, Katarina Gvozdanović, Leena Saastamoinen, Ott Laius, Ria Benkö, Silvija Žiogaitė, Stuart McTaggart, Tanja Mueller, Thais de Pando, Tomáš Tesař, Zornitsa Mitkova, Björn Wettermark
BioDrugs
· Фармакология
· 2025-08-08
☆
Comprehensive Physico-chemical and Functional Similarity Assessment Study of RGB-14-P and RGB-14-X Drug Products as Proposed Biosimilars to Denosumab Reference Products
Ágnes Szonja Garai, Dániel Hüse, Ádám Fizil, Zsolt Zólyomi, Gábor Lehoczki, Andrea Kis, Zsuzsanna Kálmán-Szekeres, Viktor Háda
BioDrugs
· Фармакология
· 2025-08-06
☆
Comprehensive Physico-Chemical and Functional Similarity Assessment of Intravenous and Subcutaneous RGB-19 Drug Products as Proposed Biosimilars to Tocilizumab Reference Product
Katalin Solti, Sarolta Timári, Tamás Faludi, Attila Iliás, Rózsa Hegedüs, Zoltán Pataj, Viktor Háda
BioDrugs
· Фармакология
· 2025-08-01
☆
Bispecific Antibodies in Hematologic Malignancies: Attacking the Frontline
Toral Shastri, Asaad Trabolsi, Artavazd Arumov, Jonathan H. Schatz
BioDrugs
· Фармакология
· 2025-08-01
☆
Individual Prescribing Incentives for Biosimilars in Selected European Countries and the USA: a Scoping Literature Review
Félix Lobo, Isabel Río-Álvarez, Ángeles Flores
BioDrugs
· Фармакология
· 2025-08-01
☆
Analytical Data and Single-Dose PK are Sufficient to Conclude Comparable Immunogenicity for Biosimilars: An Ustekinumab Case Study
Martin Schiestl, Nivedita Roy, Michael Trieb, Joseph P. Park, Elena Guillen, Gillian Woollett, Elena Wolff-Holz
BioDrugs
· Фармакология
· 2025-07-17
☆
Lipid-Lowering RNA Therapeutics for Atherosclerotic Cardiovascular Disease Prevention: A State−of−the−Art Review
Samuel D. Maidman, Robert S. Rosenson
BioDrugs
· Фармакология
· 2025-06-25
☆
Influence of Pharmacokinetic-Pharmacodynamic Failure Mechanisms on Outcomes in Biologic Therapy Sequencing in Inflammatory Bowel Disease: A Retrospective Cohort Study
Casper Steenholdt, Ruben Due Lorentsen, Jon Henneberg, Pernille Nørgaard Petersen, Jørn Brynskov
BioDrugs
· Фармакология
· 2025-06-18
☆
Comment on “Adverse Impacts of PEGylated Protein Therapeutics: A Targeted Literature Review”
Joao Goncalves, Paolo Caliceti
BioDrugs
· Фармакология
· 2025-06-17
☆
Author’s Reply to Gonçalves: “Adverse Impacts of PEGylated Protein Therapeutics: A Targeted Literature Review”
Chae Sung Lee
BioDrugs
· Фармакология
· 2025-06-17
☆
Emerging Role of Targeted Monoclonal Antibodies in Neuromyelitis Optica Spectrum Disorders
Angela H. Holian, Brian G. Weinshenker
BioDrugs
· Фармакология
· 2025-06-12
☆
The Use of Biologics for Thyroid Eye Disease
Shoaib Ugradar, Emanuil Parunakian, Raymond S. Douglas
BioDrugs
· Фармакология
· 2025-06-06
☆
Beyond Cost: Observations on Clinical and Patient Benefits of Biosimilars in Real-World Settings
Tore K. Kvien, Neil Betteridge, Ines Brückmann, Wolfram Bodenmüller, Galyna Bryn, Silvio Danese, João Gonçalves, Zorana Maravic, Carter Thorne, Laura Wingate, Paul Cornes
BioDrugs
· Фармакология
· 2025-06-05
☆
Emerging Therapy in Osteoarthritis: Mesenchymal Stem Cells, Secretomes, and Using Hydrogels to Enhance Efficacy
Qiming Pang, Jingdi Zhan, Zhuolin Chen, Lili Dong, Wei Huang
BioDrugs
· Фармакология
· 2025-05-30
☆
Demand- Versus Supply-Side Policies in Market Penetration of Biosimilars: Which is More Effective?
Gyeongseon Shin, Heejin Han, Gyeyoung Choi, Donghwan Lee, SeungJin Bae
BioDrugs
· Фармакология
· 2025-05-09
☆
Characterization of Biosimilar Monoclonal Antibodies and Their Reference Products Approved in Japan to Reveal the Quality Characteristics in Post-approval Phase
Hiroko Shibata, Akira Harazono, Masato Kiyoshi, Yoshiro Saito, Akiko Ishii-Watabe
BioDrugs
· Фармакология
· 2025-05-07